Simple jQuery Dropdowns

Browsing by Author F. Hoffmann-La Roche AG

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
1-May-2019Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 studyCaicun Zhou; Sang We Kim; Thanyanan Reungwetwattana; Jianying Zhou; Yiping Zhang; Jianxing He; Jin Ji Yang; Ying Cheng; Se Hoon Lee; Lilian Bu; Tingting Xu; Li Yang; Chao Wang; Ting Liu; Peter N. Morcos; You Lu; Li Zhang; Sun Yat-Sen University Cancer Center; Tongji University; Zhejiang Cancer Hospital; West China School of Medicine/West China Hospital of Sichuan University; Guangdong General Hospital; Asan Medical Center; SungKyunKwan University, School of Medicine; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Guangzhou Medical University; F. Hoffmann-La Roche AG; Zhejiang University; Roche Innovation Center; Jilin Cancer Hospital; Roche Pharma Development
1-Oct-2021Clinical Study of Single-Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis BEdward Gane; Man Fung Yuen; Dong Joon Kim; Henry Lik Yuen Chan; Bernadette Surujbally; Vedran Pavlovic; Sudip Das; Miriam Triyatni; Remi Kazma; Joseph F. Grippo; Simon Buatois; Annabelle Lemenuel-Diot; Ben Fillippo Krippendorff; Henrik Mueller; Yuchen Zhang; Hyung Joon Kim; Apinya Leerapun; Tien Huey Lim; Young Suk Lim; Tawesak Tanwandee; Won Kim; Wendy Cheng; Tsung Hui Hu; Cynthia Wat; Siriraj Hospital; Chang Gung Memorial Hospital; Prince of Wales Hospital Hong Kong; F. Hoffmann-La Roche AG; College of Medicine; The University of Hong Kong; University of Ulsan College of Medicine; Hallym University, College of Medicine; Middlemore Hospital, Auckland; Roche Products Limited UK; Chiang Mai University; Seoul National University College of Medicine; Roche Innovation Center; Roche Innovation Center Shanghai; Linear Clinical Research; Auckland Clinical Studies
1-Jan-1994Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARPDavid A. Fidock; Emmanuel Bottius; Karima Brahimi; I. M.D. Inge; Moelans; Masamichi Aikawa; Ruud N.H. Konings; Ulrich Certa; Petur Olafsson; Toshiyuki Kaidoh; Achara Asavanich; Claudine Guerin-Marchand; Pierre Druilhe; Institut Pasteur, Paris; Radboud University Nijmegen; Case Western Reserve University; F. Hoffmann-La Roche AG; Mahidol University
1-Jul-2021Haematological effects of oral administration of bitopertin, a glycine transport inhibitor, in patients with non-transfusion-dependent β-thalassaemiaAli T. Taher; Vip Viprakasit; Maria Domenica Cappellini; Dominik Kraus; Patrick Cech; Dietmar Volz; Erica Winter; Stephane Nave; Juergen Dukart; Omar Khwaja; Annette Koerner; Ricardo Hermosilla; Carlo Brugnara; American University of Beirut Medical Center; Children's Hospital Boston; Università degli Studi di Milano; Heinrich-Heine-Universität Düsseldorf; Mahidol University; F. Hoffmann-La Roche AG; Forschungszentrum Jülich (FZJ); Harvard Medical School; Roche Innovation Center New York
1-Nov-2019Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way ForwardRob Baltussen; Kevin Marsh; Praveen Thokala; Vakaramoko Diaby; Hector Castro; Irina Cleemput; Martina Garau; Georgi Iskrov; Alireza Olyaeemanesh; Andrew Mirelman; Mohammedreza Mobinizadeh; Alec Morton; Michele Tringali; Janine van Til; Joice Valentim; Monika Wagner; Sitaporn Youngkong; Vladimir Zah; Agnes Toll; Maarten Jansen; Leon Bijlmakers; Wija Oortwijn; Henk Broekhuizen; Evidera, United Kingdom; Belgian Health Care Knowledge Centre; Medical University of Plovdiv; Tehran University of Medical Sciences; Florida Agricultural and Mechanical University; University of Strathclyde; University of Twente; University of York; Mahidol University; F. Hoffmann-La Roche AG; Management Sciences for Health; Radboud University Nijmegen Medical Centre; University of Sheffield; Office of Health Economics; LASER Analytica; ZRx Outcomes Research Inc; Institute for Rare Diseases; Regione Lombardia
1-Feb-2022Prophylactic emicizumab for hemophilia A in the Asia-Pacific region: A randomized study (HAVEN 5)Renchi Yang; Shujie Wang; Xuefeng Wang; Jing Sun; Ampaiwan Chuansumrit; Jianfeng Zhou; Christophe Schmitt; Wanling Hsu; Jeffrey Xu; Lindong Li; Tiffany Chang; Xielan Zhao; Ramathibodi Hospital; Spark Therapeutics, Inc.; Xiangya Hospital of Central-South University; Shanghai Jiao Tong University School of Medicine; Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College; Genentech Incorporated; Peking Union Medical College Hospital; F. Hoffmann-La Roche AG; Southern Medical University; Tongji Medical College; Roche (China) Holding Ltd
1-Sep-2021Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trialMan Fung Yuen; Xue Zhou; Edward Gane; Christian Schwabe; Tawesak Tanwandee; Sheng Feng; Yuyan Jin; Miriam Triyatni; Annabelle Lemenuel-Diot; Valerie Cosson; Zenghui Xue; Remi Kazma; Qingyan Bo; Siriraj Hospital; F. Hoffmann-La Roche AG; The University of Hong Kong; The University of Auckland; Roche Innovation Center Shanghai; Brain Research New Zealand; Roche (China) Holding Ltd
20-Apr-1985TRIALS OF MEFLOQUINE IN VIVAX AND OF MEFLOQUINE PLUS 'FANSIDAR' IN FALCIPARUM MALARIAT. Harinasuta; R. Lasserre; D. Bunnag; R. Leimer; S. Vinijanont; Mahidol University; Roche Far East Research Foundation; F. Hoffmann-La Roche AG